Show
Sort by
-
Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis
-
A prospective study of alginate seeded with mature allogenic human chondrocytes in the treatment of articular cartilage defects
-
Meniscal allograft transplantation: long-term clinical results with radiological and magnetic resonance imaging correlations
-
Non-pathogenic antinuclear antibodies contribute to the clearance of apoptotic antigens released during TNF alpha blockade in spondyloarthritis (SpA)
-
Anti-TNFalpha induced apoptosis contributes to the induction of autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy (SpA)
-
Bilateral spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules, secondary infected by Aspergillus
-
Meniscal allograft transplantation: long-term clinical results with radiological and magnetic resonance imaging correlations
-
Leflunomide and methotrexate combination therapy in daily clinical practice
-
A prospective study of alginate seeded with mature allogenic human chondrocytes in the treatment of articular cartilage defects
-
Altered gut transcriptome in spondyloarthropathy
-
- Journal Article
- A2
- open access
Transplantation of viable meniscal allograft : surgical technique
-
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis
-
Anti-TNFalpha induced apoptosis contributes to the induction of autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy
-
Anti-TNF alpha induced apoptosis contributes to the induction of Autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy (SPA)
-
Growth promoting effect of human cartilage glycoprotein-39 (HC gp-39) on synovial fibroblasts
-
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis
-
Identification of synovial biomarkers of response to treatment in spondyloarthropathy
-
Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis
-
Mannose-binding lectin (MBL2) polymorphisms in rheumatoid arthritis (RA) are not associated with susceptibility or radiological progression rate
-
Alternative method to identify susceptibility genes for Crohn's disease through transcriptome analysis
-
- Journal Article
- A1
- open access
Transplantation of viable meniscal allograft : survivorship analysis and clinical outcome of one hundred cases
-
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
-
The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications
-
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity : biologic and clinical implications in autoimmune arthritis
-
Adult mesenchymal stem cell-based meniscus regeneration
-
Are biodegradable matrices seeded with chondrocytes the future treatment for cartilage defects ?
-
CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients
-
Characterisation of human knee meniscus cell phenotype
-
Growth promoting effect of human cartilage glycoprotein-39 (HC gp-39)on synovial fibroblasts
-
Local production of the cartilage protein melanoma inhibitory activity (MIA) in the inflamed joint: Disease specificity, regulation by IL-1, and association with radiological joint damage
-
Functional haplotypes of PAD14: Relevance for rheumatoid arthritis-specific synovial intracellular citruillinated proteins and anti-citrullinated protein antibodies
-
Impact of natural changes in disease activity on synovial histopathology in rheumatoid arthritis
-
Tumor necrosis factor a blockade treatment down-modulates the increased systemic and local expression of toll-like receptor 2 and toll-like receptor 4 in spondylarthropathy
-
Potent anti-inflammatory, fully dissociative compound for glucocorticoid receptor-mediated gene regulation
-
- Journal Article
- A1
- open access
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy
-
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy
-
A plant-derived compound with fully dissociated properties on glucocorticoid receptor-mediated gene regulation
-
Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation
-
Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry
-
Short and long term synovial immunumodulation by etanercept in spondyloarthropathy
-
Beta-cyclodextrin polysulphate represses TNFalpha-mediated IL-1 beta cascades in osteoarthritic chondrocytes
-
Cyclodextrin polysulphates repress IL-1 and promote chondrocyte extracellular matrix repair
-
5-year safety and efficacy follow-up in 107 spondyloarthropathy patients with continued long-term infliximab treatment
-
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis
-
Effective immunomodulation of peripheral joint pathology in spondyloarthropathy by etanercept
-
DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy
-
Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years
-
Cyclodextrin polysulphates repress IL-1 and promote the accumulation of chondrocyte extracellular matrix
-
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies
-
Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis
-
Mannose-binding lectin (MBL2) polymorphisms in rheumatoid arthritis (RA) are not associated with susceptibility or radiological progression rate
-
Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163
-
Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
-
- Journal Article
- A1
- open access
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
-
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase are pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity
-
Juvenile chronic arthritis displays synovial features distinct from both spondyloarthropathy and rheumatoid arthritis
-
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity
-
X linked agammaglobulinaemia and rheumatoid arthritis
-
Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers
-
Identification of synovial biomarkers of response to treatment in spondyloarthropathy
-
Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment
-
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
-
Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies
-
Mannose-binding lectin polymorphisms in rheumatoid arthritis and the associations with radiological progression rate and serological markers
-
IgM anti-dsDNA autoantibodies are the main antinuclear reactivity induced by infliximab but not etanercept treatment in vivo: Biological and clinical implications
-
Human cartilage glycoprotein-39 (HC gp-39) as growth factor for synovial fibroblasts
-
The cartilage protein Melanoma Inhibitory Activity (MIA) is produced locally in the arthritic joint but does not correlate with radiological joint damage
-
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase are pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity
-
Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade
-
IgM anti-dsDNA antibodies are the main anti-nuclear reactivity induced by infliximab but not etanercept treatment: biological and clinical implications
-
Mannose-binding lectin polymorphisms in rheumatoid arthritis and the associations with radiological progression rate and serological markers
-
Differential expression and response to anti-TNF alpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis
-
Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
-
Case number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis
-
- Journal Article
- A1
- open access
CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease
-
Case number 29: Ochronosis: synovial histopathological characteristics
-
Analysis of chondrocyte functional markers and pericellular matrix components by flow cytometry
-
The fibrochondrogenic potential of human mesenchymal stem cells: potential use in meniscus regeneration
-
Indispensable role of lymphotoxins alpha and beta in phenotypical and functional development of V alpha 14i NKT cells during fetal ontogeny
(2004) -
Lymphotoxins alpha and beta are indispensable for phenotypical and functional development of V alpha 14i NKT cells during fetal ontogeny
(2004) -
Lymphotoxins alpha and beta are indispensable for phenotypical and functional development of V alpha 14i NKT cells during fetal ontogeny
-
Induced intrinsic repair facilities of human articular cartilage cells: an easy in vitro assay
-
Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis
-
Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy
-
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
-
Synovial tissue proteomics in rheumatoid arthritis and spondyloarthropathy
-
Identification of synovial histopathological parameters for diagnostic classification of inflammatory arthritis by SAM analysis and neural networks
-
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations
-
Flow cytometric measurement of mRNA in living cells by FISH
-
A novel treatment of articular cartilage defects
-
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology - A prospective study in 154 consecutive patients
-
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
-
History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis
-
Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules
-
False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
-
Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis
-
Physiological levels of hydrocortisone maintain an optimal chondrocyte extracellular matrix metabolism
-
Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
-
Protein expression profiling of inflamed synovial tissue in rheumatoid arthritis, spondyloarthropathy and osteoarthritis
-
Effect of infliximab treatment on T cell cytokine responses in spondylarthropathy: comment on the article by Zou et al
-
Homeostasis of CD4+CD25+regulatory T cells in naive and arthritic mice
-
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy
-
Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis
-
Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis
-
The effect of infliximab on skin lesions in a patient with scleroderma (CREST)
-
Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker
-
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety and biological immunomodulation
-
Systematic safety follow-up in a cohort of 107 patients with spondylarthropathy treated with Infliximab: a new perspective of the role of host defence in the pathogenesis of the disease?
-
The human knee meniscus cell: Characterization of two culture models by flow cytometry and implications for tissue engineering
-
Chondrogenic differentiation of adult human bone marrow-derived stem cell cultured on a collagen scaffold or as micropellet
-
Crohn's disease patients with CARD15 variants have higher risk of developing axial joint involvement
-
CARD15 mutations in patients with spondyloarthropathy are linked with disease progression and evolution to Crohn's disease
-
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation
-
Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage
-
Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy
-
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
-
Local production of soluble CD163 in the spondyloarthropathic joint
-
Association between ASCA-positivity and carrier of a CARD-15 mutation in patients with Crohn's disease
-
Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy
-
Are biodegradable matrices seeded with mature human chondrocytes the future treatment for articular cartilage defects?
-
Cutaneous polyarteritis nodosa: A distinct entity
-
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?
-
Presence of anti-RNP-A and anti-RNP-C antibodies is inversely associated with renal symptoms of systemic lupus erythematosus
-
Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
-
Localisation of MHC Class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
-
Homeostasis of the extracellular matrix of normal and osteoarthritic human articular cartilage chondrocytes in vitro
-
Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
-
Induced intrinsic repair facilities of human articular cartilage cells: an in vitro assay
-
The presentation of the immunodominant epitope of HC gp-39 in the context of the RA-associated HLA class II molecules is specific for RA synovium
-
Microarrays uncover serum elisa levels of metalloproteinase-3 (MMP3) as a useful parameter to measure disease activity in anky-losing spondylitis (AS)
-
Rheumatoid factor and anti-citrullinated peptide antibodies in rheumatoid arthritis: Diagnostic value and association with radiological progression
-
Effect of infliximab on matrix metalloprotelinase (MMP)-1,-2,-3 and tissue inhibitors of matrix metalloproteinases (TIMP)-1,-2 in spondyloarthropathy (SpA) synovitis
-
Serum MRP 8/14 is an inflammatory marker for chronic arthritis, partially originating from the inflamed joint
-
Microarray data mining uncovers neurotrophins and their receptors as potential mediators in spondyloarthritis (SpA)
-
The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients
-
The cutting edge of spondyloarthropathy research in the millennium.
-
Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis
-
Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up
-
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy
-
Immune linkages between inflammatory bowel disease and spondyloarthropathies.
-
Gut inflammation and spondyloarthropathies.
-
Tenosynovitis with acute onset: unexpected giant cell tumour of the tendon sheath.
-
Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the getailed serotype.
-
Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
-
Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis.
-
Differential association of polymorphisms in the TNF alpha region with psoriatic arthritis but not psoriasis.
-
A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients.
-
Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles.
-
Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.
-
Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro.
-
Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.
-
Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs.
-
Control of extracellular matrix homeostasis of normal cartilage by a TGF beta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
-
Ankylosing spondylitis and bowel disease.
-
Influence of the gut and cytokine patterns in spondyloarthropathy.
-
Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al - Reply.
-
Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis : effects of treatment with cyclosporin A (Neoral®)
-
Immunomodulatory effects of anti-tumor necrosis factor α therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study
-
Current use of biologicals for the treatment of spondyloarthropathies.
-
Characteristic macro- and microscopic aspect of the synovial membrane in crystal induced arthritis
-
New treatment options in spondyloarthropathies : increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.
-
Evaluation of chondrocyte cell-associated matrix metabolism by flow cytometry.
-
Expression of host defense scavenger receptors in spondylarthropathy.
-
Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks.
-
The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
-
Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: Comment on the article by Baeten et al - Reply.
-
The Belgian-Flemish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).
-
Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alpha E beta 7 integrin.
-
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.
-
Biological freezing of human articular chondrocytes.
-
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium - Relevance to antifilaggrin autoantibodies.
-
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα
-
Flow cytometric analysis of the human articular chondrocyte phenotype in vitro.
-
Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
-
Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.
-
Interpretation of ileal biopsies: morphological features in normal and diseased mucosa.
-
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study
-
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity
-
Influence of aging on the synthesis and morphology of the aggrecans synthesized by differentiated human articular chondrocytes
-
Human cartilage gp-39+, CD16+monocytes in peripheral blood and synovium : correlation with joint destruction in rheumatoid arthritis
-
The zygapophyseal joint determines morphology of the enthesophyte
-
Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption.
-
Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers.
-
Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer associated cell lineage.
-
Non-Hodgkin's lymphoma presenting with spinal involvement.
-
Erosive and non-erosive hand osteoarthritis. Use and limitations of two scoring systems.
-
Sensitivity of the HEp-2000 substrate for the detection of Anti-SSA/Ro60 antibodies.
-
Is Tc-99m human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis?
-
Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex.
-
Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation.
-
Spondyloarthropathy is underestimated in inflammatory bowel disease: Prevalence and HLA association.
-
Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration
-
High frequency of 'missed' HLA-B loci by serologic determination in patients with spondyloarthropathy and chronic gut inflammation
-
Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients
-
Proinflammatory cytokine production and cell adhesion molecule expression compared in rheumatoid nodules and synovial membranes : comment on the article by Wikaningrum et al.
-
Crohn's disease and ulcerative colitis show different distribution patterns of CD83 positive dendritic cells
-
Polyarteritis nodosa mimicking polymyalgia rheumatica.
-
Influence of polysulfated polysaccharides on aggrecans synthesized by differentiated human articular chondrocytes.
-
T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease
-
Inflammatory bowel disease and subclinical gut inflammation in spondyloarthropathy patients are associated with increased expression of the E-cadherin/catenin complex
-
Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders.
-
Intestinal mucosa of patients with spondyloarthropathy is enriched with T cells carrying alpha E beta 7 integrin, even in the absence of histologically defined inflammation
-
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.
-
Candida glabrata arthritis: Case report and review of the literature of candida arthritis.
-
Involvement of the zygapophyseal joint in ankylosing spondylitis: Relation to the bridging syndesmophyte.
-
Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis.
-
Cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosis.
-
Effects of chemical agents and enzymes on lymphocyte surface markers
-
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.
-
Reumatische aandoeningen
-
Gastrointestinal tract and rheumatic disease
-
Viable meniscal transplantation.
-
Enteropathic arthropathies
(1998) Rheumatology. -
Enrichment of T cells carrying 137 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis
-
Altered expression of ocEß7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease
-
Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis
-
Bone and joint diseases in inflammatory bowel disease
-
Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis.
-
Bowel inflammation and the spondyloarthropathies.
-
Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.
-
A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers.
-
Extra-intestinal manifestations of enteropathies : why are the joints involved?
-
Clinical aspects of enterogenic arthropathies
-
Enteropathic arthritis
-
The clinical efficacy of Aceclofenac in the treatment of rheumatoid arthritis
-
Rheumatological manifestations of the enteropathies
-
Interferon-Gamma in the treatment of rheumatoid arthritis
-
Selection of self-reactive peptides within human aggrecan by use of a HLA-DRB1*0401 peptide binding motif.
-
Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.
-
Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis.
-
Bone scintigraphy of the hands in early stage lupus erythematosus and rheumatoid arthritis.
-
A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis.
-
Enteropathic arthritis
-
Viable meniscal transplantation.
-
The role of gut inflammation in the pathogenesis of spondyloarthropathies
-
Long-term evolution of gut inflammation in patients with spondyloarthropathy
-
Spondylarthropathies: from gut to target organs
-
Course of gut inflammation in spondylarthropathies and therapeutic consequences
-
Etiological factors and underlying conditions in patients with leucocytoclastic vasculitis
-
Numerical scoring systems for the anatomic evolution of osteoarthritis of the finger joints.
-
Recommendations for the registration of drugs used in the treatment of osteoarthritis.
-
Immunopathogenic mechanisms in spondylarthropathy and gut inflammation
(1995) Advances in mucosal immunology. In Advances in Experimental Medicine and Biology 371A+B. p.1379-1380 -
Intestin et arthrite réactionelle
-
Prognostic factors in the evolution of spondylarthropathies
-
Arthritis and abdominal symptoms
-
Systèmes de cotation numérique de l'évolution des lésions d'arthrose digitale
-
Development of immortalized human articular cartilage cell lines for use in physiological, pharmacological and toxicological in vitro investigations
-
Comparison of Aceclofenac with Diclofenac in the treatment of osteoarthritis
-
Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study
-
The evolution of spondyloarthropathies in relation to gut histology, 1: clinical aspects